JP2014519506A5 - - Google Patents

Download PDF

Info

Publication number
JP2014519506A5
JP2014519506A5 JP2014513796A JP2014513796A JP2014519506A5 JP 2014519506 A5 JP2014519506 A5 JP 2014519506A5 JP 2014513796 A JP2014513796 A JP 2014513796A JP 2014513796 A JP2014513796 A JP 2014513796A JP 2014519506 A5 JP2014519506 A5 JP 2014519506A5
Authority
JP
Japan
Prior art keywords
composition
rfurin
ppm
sugar
nonionic surfactant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014513796A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014519506A (ja
JP5797837B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/040790 external-priority patent/WO2012167271A1/en
Publication of JP2014519506A publication Critical patent/JP2014519506A/ja
Publication of JP2014519506A5 publication Critical patent/JP2014519506A5/ja
Application granted granted Critical
Publication of JP5797837B2 publication Critical patent/JP5797837B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014513796A 2011-06-02 2012-06-04 組換えフューリン製剤 Expired - Fee Related JP5797837B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161492712P 2011-06-02 2011-06-02
US61/492,712 2011-06-02
PCT/US2012/040790 WO2012167271A1 (en) 2011-06-02 2012-06-04 Formulations of recombinant furin

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015161719A Division JP6064007B2 (ja) 2011-06-02 2015-08-19 組換えフューリン製剤

Publications (3)

Publication Number Publication Date
JP2014519506A JP2014519506A (ja) 2014-08-14
JP2014519506A5 true JP2014519506A5 (https=) 2015-07-30
JP5797837B2 JP5797837B2 (ja) 2015-10-21

Family

ID=46705014

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014513796A Expired - Fee Related JP5797837B2 (ja) 2011-06-02 2012-06-04 組換えフューリン製剤
JP2015161719A Expired - Fee Related JP6064007B2 (ja) 2011-06-02 2015-08-19 組換えフューリン製剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015161719A Expired - Fee Related JP6064007B2 (ja) 2011-06-02 2015-08-19 組換えフューリン製剤

Country Status (14)

Country Link
US (2) US8877473B2 (https=)
EP (1) EP2714087B1 (https=)
JP (2) JP5797837B2 (https=)
KR (1) KR102050609B1 (https=)
CN (1) CN103889454B (https=)
AR (1) AR086672A1 (https=)
AU (2) AU2012261813B2 (https=)
BR (1) BR112013030880B1 (https=)
CA (1) CA2837948C (https=)
ES (1) ES2715289T3 (https=)
RU (1) RU2610436C2 (https=)
SG (2) SG195261A1 (https=)
TW (1) TWI586802B (https=)
WO (1) WO2012167271A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9664608B2 (en) * 2013-08-20 2017-05-30 Advanced Polymer Monitoring Technologies, Inc. Characterization of polymer and colloid solutions
TWI743023B (zh) 2014-05-21 2021-10-21 日商Km生物醫藥股份有限公司 基質金屬蛋白酶 7(mmp-7)聚集體之單體化方法
AR102048A1 (es) 2014-08-12 2017-02-01 Baxalta Inc Producción del factor x completamente procesado y funcional en un sistema de expresión de mamífero de secreción de furina
EP3642225A1 (en) 2017-06-23 2020-04-29 Baxalta Incorporated Purification of factor viii subspecies

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9000917A (nl) 1989-10-25 1991-05-16 Holland Biotechnology Farmaceutisch preparaat met endoproteolytische activiteit; werkwijze voor endoproteolytische processing van (precursor) eiwitten en voor de (micro) biologische bereiding van eiwitten.
JP4236698B2 (ja) 1990-11-26 2009-03-11 ジェネティックス インスティチュート,リミテッド ライアビリティ カンパニー 宿主細胞でのpaceの発現およびその使用法
ZA965368B (en) * 1995-07-14 1997-01-14 Novo Nordisk As A pharmaceutical formulation
AT404838B (de) 1995-11-24 1999-03-25 Immuno Ag Herstellung von proteinen aus pro-proteinen durch fusionsproteine abgeleitet von furin oder furinanalogen
US5876992A (en) * 1996-07-03 1999-03-02 Molecular Biology Resources, Inc. Method and formulation for stabilization of enzymes
US6596526B1 (en) 2000-06-09 2003-07-22 Baxter Aktiengesellschaft Furin polypeptides with improved characteristics
US7033991B2 (en) * 2001-07-16 2006-04-25 Board Of Supervisors Of Louisiana State University And Agriculture And Mechanical College Inhibiting furin with polybasic peptides
RU2373953C2 (ru) * 2003-12-19 2009-11-27 Ново Нордиск Хелс Кеа Аг Стабилизированная композиция, содержащая полипептид фактора vii
DE102006008613A1 (de) * 2006-02-24 2007-08-30 Dade Behring Marburg Gmbh Stabilisierte Zubereitungen von Serin-Endopeptidasen, deren Herstellung und Verwendung
KR101660533B1 (ko) 2007-05-22 2016-10-10 박스알타 인코퍼레이티드 인간 푸린의 분취 정제 방법
ES2735173T3 (es) * 2007-12-31 2019-12-16 Baxalta GmbH Furina recombinante sustancialmente libre de proteína animal y métodos para producir la misma

Similar Documents

Publication Publication Date Title
JP2014519506A5 (https=)
JP2018021007A5 (https=)
JP2012211150A5 (https=)
AR092470A1 (es) Formulaciones acuosas estables de adalimumab
WO2010100200A3 (en) Lyophilised antibody formulation
MX2012002861A (es) Formulaciones farmaceuticas muy concentradas.
JP2017516847A5 (https=)
MX377387B (es) Nuevo compuesto para usarse en el tratamiento de fibrosis quística.
BR112014027116A2 (pt) formulação de anticorpo
JP2015134763A5 (https=)
PH12014502778A1 (en) Antibody formulation
PH12014501937A1 (en) Pharmaceutical composition containing an antivirally active dihydroquinazoline derivative
JP2015091902A5 (https=)
JP2013518815A5 (https=)
JP2014139241A5 (https=)
WO2012076670A3 (en) Antibody formulation
JP2015525763A5 (https=)
JP2017528479A5 (https=)
JP2011513492A5 (https=)
JP2014502275A5 (https=)
RU2012138795A (ru) Жидкий состав фолликулостимулирующего гормона
JP2020511443A5 (https=)
JP2016503058A5 (https=)
WO2018096460A1 (en) Pharmaceutical compositions of glp-1 analogues
RU2013157927A (ru) Составы рекомбинантного фурина